Viewing StudyNCT04676243



Ignite Creation Date: 2024-05-06 @ 3:34 PM
Last Modification Date: 2024-10-26 @ 1:52 PM
Study NCT ID: NCT04676243
Status: WITHDRAWN
Last Update Posted: 2022-05-25
First Post: 2020-12-09

Brief Title: Daunorubicin or Idarubicin With Cytarabine Plus Quizartinib vs Physicians Choice in Newly Diagnosed FLT3-ITD AML
Sponsor: University Hospital Heidelberg
Organization: University Hospital Heidelberg

Conditions & Keywords Data

Conditions:
Name
Acute Myeloid Leukemia
Keywords:
Name View
FLT3-ITD positivity View
AML newly diagnosed View
Quizartinib added to SOC View